IMIGRAN 50 mg Comprimé pelliculé
Country: Tunisia
Language: French
Source: Ministère de la Santé, Direction de l'inspection Pharmaceutique
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
SUMATRIPTANE
Available from:
GlaxoSmithKline (Ireland) Limited
INN (International Name):
SUMATRIPTANE
Dosage:
50 mg
Pharmaceutical form:
Comprimé pelliculé
Units in package:
B/2
Class:
A
Therapeutic group:
ANALGESIQUES
Therapeutic area:
SYSTEME NERVEUX
Therapeutic indications:
Traitement des crises migraineuses aigues, avec ou sans aura.
Product summary:
Classement VEIC: Essentiel
Authorization date:
2022-01-26
